Hodgkin's lymphoma in systemic lupus erythematosus

Rheumatology

Volumn 46, Issue 5, 2007, Pages 830-832

  Bernatsky, Sasha ^a   Ramsey Goldman, R ^b   Isenberg, D ^c   Rahman, A ^c   Dooley, M A ^d   Sibley, J ^e   Boivin, J F ^f   Joseph, L ^a,f   Armitage, J ^g   Zoma, A ^h   Clarke, A ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e ROYAL UNIVERSITY HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h Hairmyres Hospital   (United Kingdom)

Author keywords

Hodgkin's lymphoma; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOGLOBULIN; METHOTREXATE; NAPROXEN; PREDNISOLONE; PROCARBAZINE; STEROID; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER INCIDENCE; CANCER REGISTRY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; CLINICAL TRIAL; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; REVIEW; RISK;

ADOLESCENT; ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HODGKIN DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK;

EID: 34347259291     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel444     Document Type: Article

References (25)

1. Mellemkjaer L, Anderson V, Linet MS, Gridley G, Hoover RN, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:761-8.
2. Bjomadal L, Lofstrom B, Yin L, Lundberg I, Ekbom A. Increased cancer incidence in a cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:66-71.
3. Bematsky S, Ramsey-Goldman R, Joseph L et al. Cancer in systemic lupus erythematosus: An international multi-centre cohort study. Arthritis Rheum 2005;52:1481-90.
4. Breslow NE, Day N. Statistical methods in cancer research. The Design and Analysis of Cohort Studies. Lyon: WHO. International Agency for Research on Cancer, 1987;302-4.
5. Gelman A, Carlin J, Stem H, Rubin H. Bayesian Data Analysis. New York: Chapman and Hall, 1995.
6. George E, Makov I, Smith A. Conjugate likelihood distributions. Scand J Stat 1993;20:147-56.
7. Goodwin JS. Remission in systemic lupus erythmatosus after combination chemotherapy for Hodgkin's disease. JAMA 1980;244:1962.
8. Efremidis A, Eiser AR, Grishman E, Rosenberg V. Hodgkin's lymphoma in an adolescent with systemic lupus erythematosus. Cancer 1984;53:142-6.
9. Netto D, Shan IA. Hodgkin's disease associated with systemic lupus erythematosus. Human Pathology 1991;22:398-401.
10. Scully RE, Mark EJ, McNeely WF et al. Case record of the Massachusetts General Hospital. N Engl J Med 1988;319:768-80.
11. Houssiau FA, Kirkove C, Asherson RA, Hughes GR, Timothy AR. Malignant lymphoma in systemic rheumatic diseases. A report of five cases. Clin Exp Rheumatol 1991;9:515-8.
12. Bhalla R, Ajmani HS, Kim WW, Swedler WI, Lazarevic MB, Skosey JL. Systemic lupus erythematosus and Hodgkin's lymphoma. J Rheumatol 1993;20:1316-20.
13. Menon S, Snaith ML, Isenberg DA. The association of malignancy with SLE: an analysis of 150 patents under long-term review. Lupus 1993;2:177-81.
14. Rakfal SM, Deutsch M. Radiotherapy for malignancies associated with lupus: Case reports of acute and late reactions. Am J Clin Oncol 1998;21:54-7.
15. Schachna L, Ryan PF, Schwarer AP. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis Rheum 1998;41:2271-2.
16. Merino R, de Inocencio J, Garcia-Miguel P, Garcia-Consuegra J. Lymphoproliferative disorders in paediatric rheumatic diseases. A report of two cases. Clin Exp Rheumatol 2004;22:649-50.
17. Patel P, Moazzam N, Potti A, Mehdi SA. Azathioprine induced Hodgkin's lymphoma: A case report and review of literature. Am J Clin Oncol 2005;28:427-8.
18. Mauch PM, Kalish LA, Marcus KC et al. Long-term survival in Hodgkin's disease. Cancer J Sci Am 1995;1:33.
19. Rindi L, Eisner MP, Kosary CL et al., eds. SEER Cancer Statistica Review, 1975-2002. Bethesda, MD, National Cancer Institute, 2006.
20. Haybittle JL, Easterling MJ, Bennett MH et al. Review of british national lymphoma investigation studies of Hodgkin's disease and development of prognostic index. The Lancet 1985;325:967-72.
21. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. N Engl J Med 1998;339:1506-14.
22. Cartwright R, Clayden D, Jack A et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer 1999;35:627-33.
23. Yung L, Linch D. Hodgkin's lymphoma. The Lancet 2003;361:943-51.
24. Kuppers R, Rajewsky K. The origin of Hodgkin and Reed/Stemberg cells in Hodgkin's disease. Annu Rev Immunol 1998;16:471-93.
25. Bematsky S, Ramsey-Goldman R, Rajan R et al. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis 2005;64:1507-9.